Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccination strategies aimed at inducing broadly neutralizing antibodies (bNAbs). To limit the exposure of rare isolate-specific antigenic residues/determinants we generated a SOSIP trimer based on a consensus sequence of all HIV-1 group M isolates (ConM). The ConM trimer displays the epitopes of most known bNAbs and several germline bNAb precursors. The crystal structure of the ConM trimer at 3.9 Å resolution resembles that of the native Env trimer and its antigenic surface displays few rare residues. The ConM trimer elicits strong NAb responses against the autologous virus in rabbits and macaques that are significantly enhanced when it is presented ...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
SummaryBroadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) ...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based prophy...
The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutra...
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer r...
Summary: The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-bas...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
HIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, ...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Human immunodeficiency virus type 1 (HIV-1) vaccine development requires selection of appropriate en...
Stabilization of the HIV-1 Envelope glycoprotein trimer (Env) in its native pre-fusion closed confor...
PURPOSE OF REVIEW: To provide an update on the latest developments in the field of HIV-1 antibody-ba...
AbstractHIV-1 envelope glycoproteins (Env) and Env-based immunogens usually do not interact efficien...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
SummaryBroadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) ...
Stabilized HIV-1 envelope glycoproteins (Env) that resemble the native Env are utilized in vaccinati...
The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-based prophy...
The HIV-1 envelope glycoprotein (Env) trimer is the key target for vaccines aimed at inducing neutra...
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer r...
Summary: The HIV-1-envelope glycoprotein (Env) is the main target of antigen design for antibody-bas...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
HIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, ...
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer ...
Human immunodeficiency virus type 1 (HIV-1) vaccine development requires selection of appropriate en...
Stabilization of the HIV-1 Envelope glycoprotein trimer (Env) in its native pre-fusion closed confor...
PURPOSE OF REVIEW: To provide an update on the latest developments in the field of HIV-1 antibody-ba...
AbstractHIV-1 envelope glycoproteins (Env) and Env-based immunogens usually do not interact efficien...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
SummaryBroadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) ...